Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia.

Mortamais M, Artero S, Ritchie K.

Int Rev Psychiatry. 2013 Dec;25(6):686-98. doi: 10.3109/09540261.2013.838151. Review.

2.

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR.

Arch Neurol. 2008 Jan;65(1):94-100. doi: 10.1001/archneurol.2007.23.

PMID:
18195145
3.

White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.

Nolze-Charron G, Mouiha A, Duchesne S, Bocti C; Alzheimer's Disease Neuroimaging Initiative1.

J Alzheimers Dis. 2015;46(4):855-62. doi: 10.3233/JAD-140618.

PMID:
26402625
4.

Amnestic multiple cognitive domains impairment and periventricular white matter hyperintensities are independently predictive factors progression to dementia in mild cognitive impairment.

Lee HK, Lee YM, Park JM, Lee BD, Moon ES, Chung YI.

Int J Geriatr Psychiatry. 2014 May;29(5):526-32. doi: 10.1002/gps.4035. Epub 2013 Oct 10.

PMID:
24123391
5.

Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Yoshita M, Fletcher E, Harvey D, Ortega M, Martinez O, Mungas DM, Reed BR, DeCarli CS.

Neurology. 2006 Dec 26;67(12):2192-8.

6.

The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.

Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.

Eur J Neurol. 2014 Jun;21(6):922-e50. doi: 10.1111/ene.12412. Epub 2014 Mar 24.

PMID:
24661277
7.

White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age.

Boyle PA, Yu L, Fleischman DA, Leurgans S, Yang J, Wilson RS, Schneider JA, Arvanitakis Z, Arfanakis K, Bennett DA.

Ann Clin Transl Neurol. 2016 Sep 1;3(10):791-800. eCollection 2016 Oct.

8.
9.

Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment.

Debette S, Bombois S, Bruandet A, Delbeuck X, Lepoittevin S, Delmaire C, Leys D, Pasquier F.

Stroke. 2007 Nov;38(11):2924-30. Epub 2007 Sep 20.

10.

Progression of White Matter Disease and Cortical Thinning Are Not Related in Older Community-Dwelling Subjects.

Dickie DA, Karama S, Ritchie SJ, Cox SR, Sakka E, Royle NA, Aribisala BS, Hernández MV, Maniega SM, Pattie A, Corley J, Starr JM, Bastin ME, Evans AC, Deary IJ, Wardlaw JM.

Stroke. 2016 Feb;47(2):410-6. doi: 10.1161/STROKEAHA.115.011229. Epub 2015 Dec 22.

11.

White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.

Dalaker TO, Larsen JP, Dwyer MG, Aarsland D, Beyer MK, Alves G, Bronnick K, Tysnes OB, Zivadinov R.

Neuroimage. 2009 Oct 1;47(4):2083-9. doi: 10.1016/j.neuroimage.2009.06.020. Epub 2009 Jun 16.

PMID:
19539037
12.

White matter hyperintensities as early and independent predictors of Alzheimer's disease risk.

Mortamais M, Artero S, Ritchie K.

J Alzheimers Dis. 2014;42 Suppl 4:S393-400. doi: 10.3233/JAD-141473. Review.

PMID:
25261452
13.

Association of intracranial atherosclerotic stenosis with severity of white matter hyperintensities.

Park JH, Kwon HM, Lee J, Kim DS, Ovbiagele B.

Eur J Neurol. 2015 Jan;22(1):44-52, e2-3. doi: 10.1111/ene.12431. Epub 2014 Apr 9.

PMID:
24712717
14.

White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.

Prasad K, Wiryasaputra L, Ng A, Kandiah N.

Dement Geriatr Cogn Disord. 2011;31(6):431-4. doi: 10.1159/000330019. Epub 2011 Jul 15.

PMID:
21757908
15.

Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.

Hawkins KA, Emadi N, Pearlson GD, Winkler AM, Taylor B, Dulipsingh L, King D, Pittman B, Blank K.

Metab Brain Dis. 2017 Jun;32(3):849-857. doi: 10.1007/s11011-017-9980-9. Epub 2017 Mar 3.

PMID:
28255864
16.

Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.

Shin J, Choi S, Lee JE, Lee HS, Sohn YH, Lee PH.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):315-21. doi: 10.1136/jnnp-2011-300872. Epub 2012 Jan 6.

PMID:
22228726
17.

Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase.

He J, Iosif AM, Lee DY, Martinez O, Chu S, Carmichael O, Mortimer JA, Zhao Q, Ding D, Guo Q, Galasko D, Salmon DP, Dai Q, Wu Y, Petersen RC, Hong Z, Borenstein AR, DeCarli C.

Arch Neurol. 2010 Oct;67(10):1231-7. doi: 10.1001/archneurol.2010.230.

18.

Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.

Xiong Y, Wong A, Cavalieri M, Schmidt R, Chu WW, Liu X, Wong KS, Mok V.

Neurotherapeutics. 2014 Jul;11(3):606-11. doi: 10.1007/s13311-014-0270-5.

19.

Genes from a translational analysis support a multifactorial nature of white matter hyperintensities.

Lopez LM, Hill WD, Harris SE, Valdes Hernandez M, Munoz Maniega S, Bastin ME, Bailey E, Smith C, McBride M, McClure J, Graham D, Dominiczak A, Yang Q, Fornage M, Ikram MA, Debette S, Launer L, Bis JC, Schmidt R, Seshadri S, Porteous DJ, Starr J, Deary IJ, Wardlaw JM.

Stroke. 2015 Feb;46(2):341-7. doi: 10.1161/STROKEAHA.114.007649. Epub 2015 Jan 13.

20.

White matter hyperintensities and cognition: testing the reserve hypothesis.

Brickman AM, Siedlecki KL, Muraskin J, Manly JJ, Luchsinger JA, Yeung LK, Brown TR, DeCarli C, Stern Y.

Neurobiol Aging. 2011 Sep;32(9):1588-98. doi: 10.1016/j.neurobiolaging.2009.10.013. Epub 2009 Nov 18.

Supplemental Content

Support Center